Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2021 $ 2 $ 267,609 $ (250,416) $ 17,195
Beginning balance, shares at Dec. 31, 2021 77 247,105      
Stock based compensation 102 102
Stock based compensation, shares   30      
Net income (loss) (2,845) $ (2,845)
Issuance of common stock from the cashless exercise of warrants, shares        
Ending balance at Mar. 31, 2022 $ 2 267,711 (253,261) $ 14,452
Ending balance, shares at Mar. 31, 2022 77 247,135      
Beginning balance at Dec. 31, 2022 $ 5 268,154 (262,455) 5,704
Beginning balance, shares at Dec. 31, 2022 283 542,145      
Stock based compensation 86 86
Stock based compensation, shares   15      
Net income (loss) (293) (293)
Common stock issued for cash, net of cash fees $ 20 4,437 4,457
Common stock issued for cash, net of cash fees, shares   1,980,000      
Prefunded warrants issued for cash, net of cash fees 383 383
Extinguishment of derivative liability upon exercise of warrant 5,502 5,502
Issuance of common stock from the exercise of prefunded warrants for cash $ 2 (2)
Issuance of common stock from the exercise of prefunded warrants for cash, shares   170,000      
Issuance of common stock from the cashless exercise of warrants $ 13 (13)
Issuance of common stock from the cashless exercise of warrants, shares   1,337,600    
Redemption of preferred stock (2) $ (2)
Redemption of preferred stock, shares (1)        
Issuance of agent warrants 108 108
Round up shares issued in reverse split
Round up shares issued in reverse split, shares   20,475      
Ending balance at Mar. 31, 2023 $ 40 $ 278,653 $ (262,748) $ 15,945
Ending balance, shares at Mar. 31, 2023 282 4,050,235